Future studies should also examine the expression of LEDGF/p75 in relationship to tumor stage and grade, tumor microenvironment, tumor mutational status, and therapeutic modalities, in large cohorts of racially/ethnically diverse cancer patients with annotated genomics, transcriptomics, and clinicopathological data. Here, PSIP1 is linked to cancer.